In conclusion, this study employed both human and murine cell lines for in vitro and in vivo experiments, elucidating the role of CYP4F3 in regulating CRC progression, predominantly through regulating NRF2-mediated ferroptosis. The gene discussed is CYP4F3; the disease is colorectal carcinoma.